An External Control Arm Study in Non-Small Cell Lung Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
A study to create control arms using current and future information in patients with lung cancer.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek powyżej 18 lat
- •Potwierdzony rozpoznaniem rak płuca w stadium zaawansowanym lub z przerzutami
- •Ogólny stan zdrowia pozwalający na aktywność codzienną (ECOG 0-1) w ciągu ostatnich 4 tygodni
- •Spodziewana długość życia dłuższa niż 3 miesiące
- •Możliwość zrozumienia i podpisania zgody na udział w badaniu
- •Widoczne zmiany nowotworu na zdjęciach (CT, MRI lub PET)
✗ Disqualifies
- •Aktualny udział w innym badaniu klinicznym z nowym lekiem
- •Bieżące leczenie systemowe innego nowotworu
- •Możliwość leczenia z zamiarem całkowitego wyleczenia
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 10, 2026
- Sex
- No restrictions
Locations (8)
Pacific Cancer Care
Monterey, United States
Bayhealth Medical Center, Kent Campus
Dover, United States
Bayhealth Medical Center- Sussex Campus
Milford, United States
Northwest Oncology and Hematology
Barrington, United States
Northwest Oncology and Hematology
Elk Grove, United States
Northwest Oncology and Hematology
Hoffman Estates, United States
Northwest Oncology and Hematology
Rolling Meadows, United States
Oncology Consultants
Houston, United States
Trial contact
Alexander Baskoro
Anushi Bulumulle, MD
PRINCIPAL_INVESTIGATOR
Ruby Davis
Iftekhar Khan, MD
PRINCIPAL_INVESTIGATOR
Nowsheen Azeemuddin
Roberto Montoya, MD
PRINCIPAL_INVESTIGATOR
Research Office
Luis Campos, MD
PRINCIPAL_INVESTIGATOR
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/11/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.